Delirium from Diclazepam

Delirium is a profound disturbance of consciousness that goes far beyond the typical cognitive alterations produced by most psychoactive substances. It is characterized by a global impairment of cognitive function — the person cannot maintain focused attention, cannot orient themselves in time or place, cannot follow or produce coherent speech, and often cannot distinguish hallucinated experiences from reality. Unlike the altered states produced by psychedelics or dissociatives, where a core thread of awareness is usually maintained, delirium involves a fundamental breakdown of the capacity for organized thought.

The hallmark features of delirium include fluctuating levels of awareness (alternating between agitation and stupor),disorientation (not knowing where one is, what day it is, or sometimes who one is),incoherent speech (fragmented, tangential, or nonsensical verbalizations),perceptual disturbances (vivid hallucinations, often of mundane but nonexistent objects, people, or creatures), andpsychomotor abnormalities (restless picking at clothing, repetitive purposeless movements, or catatonic stillness). A particularly characteristic feature of substance-induced delirium is that the person may attempt to interact with hallucinated objects or people — holding conversations with invisible entities, reaching for things that are not there, or trying to perform ordinary tasks in completely inappropriate contexts.

In the context of substance use, delirium is most strongly associated with anticholinergic/deliriant compounds — diphenhydramine (Benadryl) at high doses, datura (scopolamine), and related tropane alkaloids. These substances produce delirium by blocking muscarinic acetylcholine receptors throughout the brain, disrupting the cholinergic systems essential for attention, memory, and coherent cognitive processing. Delirium can also result fromstimulant psychosis during extended binges with sleep deprivation,alcohol withdrawal (delirium tremens),benzodiazepine withdrawal, extreme hyperthermia, and severe serotonin syndrome.

What makes delirium particularly dangerous compared to other altered states is the complete loss of insight. A person experiencing a difficult psychedelic trip typically knows they have taken a substance and that the experience will end. A person in delirium has lost this awareness entirely — they do not know they are intoxicated, they cannot evaluate their own state, and they may act on hallucinated perceptions with full conviction. This leads to behavior that is unpredictable, irrational, and potentially life-threatening: wandering into traffic, jumping from heights, violent self-defense against perceived threats, or ingesting additional harmful substances.

Harm reduction note: Delirium is a medical emergency, not a recreational experience. If someone is exhibiting signs of delirium — confusion, incoherent speech, inability to recognize familiar people, interaction with things that are not there — they need medical attention. Do not leave them unsupervised. Deliriant substances (high-dose diphenhydramine, datura, and related plants) are among the most consistently negative and dangerous psychoactive experiences reported, and the overwhelming consensus in harm reduction communities is that they should be avoided entirely.